私募产品新发火爆！“新星”异军突起！精砚私募、顽岩资产、上衍私募等夺冠！

Core Viewpoint - The private equity industry has experienced a strong recovery in 2023, with significant growth in both product performance and new product issuance, reflecting a robust market sentiment and investment opportunities [2][3]. Performance Overview - As of October 17, 2023, the average return of 5,252 private equity products with performance data reached 25.51%, significantly outperforming the market, with 579 products yielding over 50% returns [2]. - The issuance of new private equity products surged to 9,251 in the first nine months of 2023, marking a year-on-year increase of 103.77% [2]. New Product Performance - Among the newly established private equity products in 2023, 252 products with nearly six months of performance data reported an average return of 19.64% in the last six months and 21.42% year-to-date [3]. Strategy-Specific Highlights Subjective Long-Only Strategies - The average return for 72 new subjective long-only products was 26.02%, with 94.44% of these products generating positive returns [4]. - The top three products in this category were managed by Jingyan Private Equity, Zeying Private Equity, and Yingci Fund [4]. Quantitative Long-Only Strategies - The average return for 48 new quantitative long-only products was 31.58%, with 97.92% of these products achieving positive returns [7]. - The leading products in this category were managed by Wanyan Asset, Liangying Investment, and Huijin Asset [7]. CTA Strategies - The average return for 28 new CTA strategy products was 10.82%, with the top three products managed by Chiying Private Equity, Zhixin Rongke, and Chongsheng Investment [10]. - The leading product in this category was managed by Qian Jun of Chiying Private Equity, which capitalized on the rising gold market [12]. Macro Strategies - The average return for 24 new macro strategy products was 13.03%, with the top three products managed by Shanghai Shangyan Private Equity, Ruyuan Private Equity, and Jiaorui (Shanghai) Investment [14]. - The leading product in this category was managed by Chen Hao of Shanghai Shangyan Private Equity, focusing on macro-driven factors [15][16].